3.4.3. Allergic emergencies
Prescribing Notes:
- Includes autoinjector devices for self-administration (e.g. Jext®, Epipen® and Emerade® range of devices)
- It should be noted that the recommended administration technique for different devices can vary. When a device is changed, either by the manufacturer or by changing brand, it is essential that patients and carers receive clear instructions on the use of the device prescribed.
Patients should be made aware of the importance of checking expiry dates.
Restrictions:
Use for the routine prevention of recurrent attacks of hereditary angioedema (HAE) is restricted to specialist use in patients who experience ≥ two clinically significant attacks per month.
Restrictions:
Treatment of acute angioedema attacks in adults and adolescents with hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency is restricted to specialist use only.
Restrictions:
It is restricted to specialist use only on the advice of the Immunology Service.
Restrictions:
Restricted to specialist use only in patients with hereditary angioedema (HAE) type I or II, who would otherwise be considered for long-term prophylaxis treatment with C1-esterase inhibitor.